Adinarayana Kunamneni | Neuroscience | Innovative Research Award

Published on by Best Achievements

Innovative Research Award

Adinarayana Kunamneni
Mayo Clinic, United States

Adinarayana Kunamneni
Affiliation Mayo Clinic
Country United States
Scopus ID 9133681000
Documents 67
Citations 3,491
h-index 26
Subject Area Neuroscience
Event Global Best Achievements Awards
ORCID 0000-0002-9952-2209

The Innovative Research Award recognizes distinguished scholarly achievements and sustained contributions to scientific advancement. Adinarayana Kunamneni of Mayo Clinic has established a notable academic profile through interdisciplinary research, publication productivity, citation influence, and contributions to neuroscience-related investigations. His research record demonstrates engagement with contemporary scientific challenges and reflects a commitment to advancing knowledge through collaborative and evidence-based inquiry.[1]

Abstract

Adinarayana Kunamneni is a researcher affiliated with Mayo Clinic whose scholarly activities have contributed to the advancement of neuroscience and related biomedical disciplines. With a publication portfolio comprising numerous peer-reviewed documents, his work demonstrates sustained engagement in scientific investigation, interdisciplinary collaboration, and knowledge dissemination. Citation indicators and research metrics reflect academic visibility and influence within the scientific community. The Innovative Research Award recognizes researchers whose achievements exemplify originality, methodological rigor, and meaningful impact. Kunamneni’s academic record, publication productivity, and contribution to scientific understanding support consideration for recognition through this prestigious international award program.[1][2]

Keywords

Innovative Research Award, Adinarayana Kunamneni, Mayo Clinic, Neuroscience, Scientific Research, Citation Impact, Research Excellence, Academic Recognition, Biomedical Science, Scholarly Contributions.

Introduction

Scientific innovation relies upon rigorous investigation, collaborative inquiry, and the effective dissemination of research outcomes. Researchers who consistently contribute high-quality scholarship play an important role in advancing scientific knowledge and supporting evidence-based progress. The Innovative Research Award acknowledges individuals whose academic accomplishments demonstrate originality, productivity, and measurable influence across their respective fields. Adinarayana Kunamneni’s research activities align with these objectives through sustained scholarly engagement and publication contributions within neuroscience-related domains.[1]

Research Profile

The research profile of Adinarayana Kunamneni reflects a productive academic career characterized by peer-reviewed publications, interdisciplinary collaborations, and measurable citation performance. Affiliated with Mayo Clinic, he has contributed to scientific investigations addressing topics within neuroscience and biomedical research. Bibliometric indicators, including publication volume, citation counts, and h-index values, demonstrate sustained scholarly visibility and engagement with the international research community.[1]

Research Contributions

Kunamneni’s research contributions encompass scientific studies that advance understanding within neuroscience and related biomedical disciplines. His work has supported the development of new knowledge, facilitated interdisciplinary approaches, and contributed to scholarly discussions through publication in recognized academic venues. These efforts demonstrate commitment to methodological quality, scientific integrity, and the communication of findings that can inform future investigations and practical applications.[3]

Publications

The researcher has authored and co-authored numerous scholarly publications indexed within major scientific databases. These works contribute to the broader body of literature addressing neuroscience, biomedical innovation, and translational research. Publication activity demonstrates sustained academic productivity and participation in international scientific discourse while supporting the dissemination of research outcomes to diverse scholarly audiences.[1]

Research Impact

Research impact may be evaluated through citation performance, scholarly visibility, and influence on subsequent scientific studies. With thousands of citations and a substantial h-index, Kunamneni’s work has attracted attention from researchers across related disciplines. These indicators suggest that his publications contribute meaningfully to ongoing scientific discussions and have informed subsequent investigations within the broader research ecosystem.[1][4]

Award Suitability

The Innovative Research Award seeks to recognize individuals who demonstrate sustained research excellence, measurable impact, and meaningful scholarly contributions. Adinarayana Kunamneni’s publication record, citation influence, institutional affiliation, and research productivity align with many of the evaluation criteria commonly associated with international academic recognition programs. His achievements illustrate a commitment to advancing scientific understanding through rigorous investigation and dissemination of knowledge.[1][5]

Conclusion

Adinarayana Kunamneni’s academic profile reflects consistent scholarly engagement, publication productivity, and citation impact within neuroscience and related biomedical fields. Through contributions to scientific literature and participation in collaborative research initiatives, he has demonstrated qualities associated with research excellence. The Innovative Research Award provides an appropriate framework for recognizing such achievements and highlighting their value within the international scientific community.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Adinarayana Kunamneni, Author ID 9133681000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=9133681000
  2. ORCID. (n.d.). Researcher profile: Adinarayana Kunamneni.
    https://orcid.org/0000-0002-9952-2209
  3. International Journal of Molecular Sciences. (2023). Rapid Generation and Molecular Docking Analysis of Single-Chain Fragment Variable (scFv) Antibody Selected by Ribosome Display Targeting Cholecystokinin B Receptor (CCK-BR) for Reduction of Chronic Neuropathic Pain.
    https://doi.org/10.3390/ijms241311035
  4. Neuromolecular medicine. (2019). Exosomes Secreted by the Cocultures of Normal and Oxygen-Glucose-Deprived Stem Cells Improve Post-stroke Outcome.
    https://doi.org/10.1007/s12017-019-08540-y
  5. Global Best Achievements Awards. (n.d.). Innovative Research Award evaluation framework and recognition program.
    https://bestachievements.com/

Asmaa Morgan Farahat Khatap | Neuroscience | Research Excellence Award

Published on by Best Achievements

Assist. Prof. Dr. Asmaa Morgan Farahat Khatap | Neuroscience | Research Excellence Award

Prince Sattam Ibn Abdulaziz | Saudi Arabia

Asmaa Morgan Farahat Khatap is an Assistant Professor in the field of Maternal and Child Health Nursing with academic affiliations at the College of Nursing, Prince Sattam bin Abdulaziz University, Saudi Arabia, and the Faculty of Nursing, Suez Canal University, Egypt. She is a clinician–researcher whose work integrates nursing practice, education, and applied research to improve maternal, neonatal, and women’s health outcomes. Her scholarly focus centers on patient-centered and preventive care, with particular attention to pregnancy-related conditions, women’s health education, and evidence-based nursing interventions. She is deeply committed to translating research findings into practical guidelines, educational programs, and clinical strategies that empower women, nurses, and healthcare providers. Her research philosophy emphasizes contextual relevance, interdisciplinary collaboration, and sustainable impact, recognizing the complex medical, psychosocial, and behavioral dimensions of maternal health. Through collaborative work across nursing, obstetrics, public health, and health education, she contributes to advancing knowledge on maternal risk reduction, health promotion, and quality of care. In addition to her research activities, she is actively involved in teaching, mentoring, and professional development, striving to strengthen nursing competencies and promote lifelong learning. Her work reflects a strong dedication to improving healthcare delivery, supporting vulnerable populations, and fostering meaningful, practice-oriented advancements in maternal and child health.

Citation Metrics (Scopus)

20
15
10
5
0

Citations
14

Documents
6

h-index
2

Citations

Documents

h-index


View Scopus Profile View Orcid Profile

Featured Publications


Targeting of NF‐κB/NLRP3 Axis in Gestational Diabetes Mellitus

– American Journal of Reproductive Immunology

Effect of Practicing Pelvic Tilt Exercise on the Intensity of Lumbopelvic Pain among Pregnant Women

– Trends in Nursing and Health Care Journal

Assessment of Factors Negatively Affecting Nurses’ Performance in Obstetric Ward: A Descriptive Study in Ismailia Hospitals

– Sohag Journal of Nursing Science

Effect of Advanced Nursing Management Guidelines on Nurses’ Knowledge Regarding Emergency Obstetrical Care

– The Egyptian Journal of Hospital Medicine

A quasi-experimental evaluation of simulation-based versus video-assisted training on ACLS knowledge and skills among emergency nurses

– International Journal of Innovative Research and Scientific Studies

Hina Singh | Neuroscience | Best Researcher Award

Published on by Best Achievements

Dr. Hina Singh | Neuroscience | Best Researcher Award 

University of California, Riverside | United States

Dr. Hina Singh, Ph.D., currently serves as an Assistant Project Scientist in the Division of Biomedical Sciences at the School of Medicine, University of California, Riverside, USA. Her research focuses on neuroHIV, neuroimmunology, and nanobiotechnology, with particular expertise in investigating the role of interferon signaling in HIV-associated neurocognitive disorders and methamphetamine-induced neurotoxicity. She possesses extensive experience in neuronal and microglial cell culture, molecular biology, and advanced microscopy techniques, alongside proficiency in nanoparticle synthesis and biosensor development. Dr. Singh’s scholarly contributions are reflected in 55 peer-reviewed publications, accumulating over 2,190 citations and an impressive h-index of 23, highlighting her significant impact in biomedical and nanoscience research. Her scientific journey spans diverse areas, including superparamagnetic iron oxide nanoparticles, gold nanoparticle-based biosensors, and the synthesis of biocompatible nanomaterials for therapeutic applications. She has also been actively involved in mentoring students and collaborating on interdisciplinary research projects bridging neurobiology and nanotechnology. A recipient of multiple international honors such as the Early Career Investigator Travel Award and President’s Scholarship, Dr. Singh continues to advance translational research aimed at understanding molecular mechanisms underlying neuroinflammation, viral neuropathogenesis, and neuroprotective therapeutic strategies.

Profile: Scopus | Orcid 

Featured Publications 

Singh, H., et al. (2025). Medical importance and pharmacokinetics of gold nanoparticles in the human body. Molecular Cancer.

Singh, H., et al. (2025). EphB2-mediated ephrin-B reverse signaling on microglia drives an anti-viral, but inflammatory and neurotoxic response associated with HIV. Journal of Neuroinflammation.

Singh, H., et al. (2025). Advanced nanomaterials for cancer therapy: Gold, silver, and iron oxide nanoparticles in oncological applications.

Singh, H., et al. (2025). Advances in precision oncology using patient-derived organoids and functional biomaterials.

Singh, H., et al. (2024). Interferon-β deficiency alters brain response to chronic HIV-1 envelope protein exposure in a transgenic model of NeuroHIV. Brain, Behavior, and Immunity.

Falguni Goel | Neuropharmacology | Women Researcher Award

Published on by Best Achievements

Ms Falguni Goel | Neuropharmacology | Women Researcher Award

Ms. Falguni Goel, MIET, India.

🔬 Ms. Falguni Goel is a dedicated researcher and Assistant Professor at MIET, Meerut, specializing in neuropharmacology and molecular biotechnology. With a passion for understanding neuropsychiatric disorders like Huntington’s and Parkinson’s, she brings innovation through herbal drug discovery and advanced lab techniques. 🧠 She holds multiple patents, has published in high-impact journals 📚, and excels in zebrafish-based research. 🎯 Falguni’s goal is to blend science, creativity, and compassion to make breakthroughs in neurotherapeutics. 💡

Profile

Scopus Profile

Orcid profile

Google Scholar Profile

🎓 Early Academic Pursuits

Falguni Goel, has demonstrated exceptional commitment to science from an early age. Her academic journey began with a passion for biology and evolved into a specialized interest in neuropharmacology and molecular biotechnology. With a solid foundation laid during her M.Pharm studies, she completed a compelling thesis titled “Protective Effect of Diacerein in Quinolinic Acid Induced Huntington’s Like Symptoms in Adult Zebrafish Targeting GSK-3β Signalling”, showcasing her early focus on neurodegenerative research. 🧬📘

💼 Professional Endeavors

Currently serving as an Assistant Professor at MIET, Meerut, Falguni blends academic leadership with active research. She is also an enthusiastic educator and mentor, committed to shaping the next generation of pharmaceutical and neuroscience researchers. Her drive for innovation is deeply tied to her academic and professional goals. 🎓📚

🔬 Contributions and Research Focus On Neuropharmacology 

Falguni’s research is sharply focused on neuropsychiatric disorders, particularly Huntington’s, Parkinson’s, Dementia, Autism, and depression. She explores molecular pathways, diagnostic markers, and behavioral models in zebrafish and rodents to understand these conditions. Her work emphasizes drug development using both synthetic and herbal phytochemicals, aiming to bridge traditional and modern approaches in neuroscience. 🧪🧠🌿

🌍 Impact and Influence

Her impactful research is evident in numerous high-impact publications and national patents. Her findings have not only advanced understanding of neurological disorders but also introduced new experimental methodologies and apparatus for behavioral studies. She has set benchmarks, particularly in zebrafish brain studies and drug delivery techniques. 🏅💡

🧠 Research Skills

Falguni is skilled in a wide array of research techniques:

  • Zebrafish and rodent behavioral modeling 🐟🐀

  • Brain dissection, histopathology, and drug delivery via multiple routes 🧠💉

  • Molecular techniques including Western Blot, PCR, ELISA, HPLC, and cryo-sectioning 🧫🔬

  • Biochemical analysis of neurotransmitters and signaling proteins 🧬🧪

  • Expertise in behavioral software (AnyMaze), data analysis tools (GraphPad Prism), and manuscript writing 📊📝

She is known for pioneering i.c.v. administration in zebrafish in India and innovating several research apparatuses enhancing experimental reliability.

🏅 Awards and Honors

Falguni’s scholarly achievements have earned her numerous accolades, including multiple granted patents by the Government of India. Her innovations in experimental neuroscience are widely recognized, including devices such as the Zebrafish Behavioral Exploration Apparatus and Electro-convulsiometer Ring for Rodents. Her early participation in the national platform Pariksha pe Charcha with Prime Minister Modi also reflects her active civic engagement. 🥇📜

🏛️ Legacy and Future Contributions

With over a dozen patents and 20+ publications already under her name at just 23, Falguni Goel’s legacy is only beginning. She envisions pioneering more AI-integrated health solutions and developing innovative tools to advance neuropharmacology. Her dedication promises substantial contributions to neuroscience, both academically and clinically, in the coming decades. 🚀🧠🧑‍🔬

Publications Top Notes

📄 Apigenin protects melanocytes and improve tyrosinase activity in a hydroquinone induced vitiligo mouse model targeting P38 MAP kinase signaling: histopathology and …
📚 Naunyn-Schmiedeberg’s Archives of Pharmacology
🗓️ 2024

🧠 Protective effects of diacerein against quinolinic acid–induced Huntington’s disease–like symptoms in adult zebrafish by targeting GSK-3β signalling
📚 Naunyn-Schmiedeberg’s Archives of Pharmacology
🗓️ 2025

🧬 Beyond dopamine: novel therapeutic pathways for Parkinson’s disease through receptor signaling
📚 CNS & Neurological Disorders – Drug Targets
🗓️ 2025

🧩 From Genetics to Function: the Role of ABCA12 in Autism Neurobiology
📚 Journal of Molecular Neuroscience
🗓️ 2025

🤖 The Future of Drug Development: Leveraging AI for Faster and Safer Innovation
📚 Journal of Advanced Scientific Research
🗓️ 2025